Vivoryon Therapeutics (Netherlands) Market Value
| VVY Stock | 2.02 0.02 0.98% |
| Symbol | Vivoryon |
Vivoryon Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vivoryon Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vivoryon Therapeutics.
| 05/29/2024 |
| 11/25/2024 |
If you would invest 0.00 in Vivoryon Therapeutics on May 29, 2024 and sell it all today you would earn a total of 0.00 from holding Vivoryon Therapeutics NV or generate 0.0% return on investment in Vivoryon Therapeutics over 180 days. Vivoryon Therapeutics is related to or competes with Galapagos, Koninklijke BAM, Fugro NV, PostNL NV, and AMG Advanced. More
Vivoryon Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vivoryon Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vivoryon Therapeutics NV upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 51.09 | |||
| Value At Risk | (4.90) | |||
| Potential Upside | 4.37 |
Vivoryon Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vivoryon Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vivoryon Therapeutics' standard deviation. In reality, there are many statistical measures that can use Vivoryon Therapeutics historical prices to predict the future Vivoryon Therapeutics' volatility.| Risk Adjusted Performance | 0.0068 | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | (0.03) |
Vivoryon Therapeutics Backtested Returns
Currently, Vivoryon Therapeutics NV is dangerous. Vivoryon Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.003, which indicates the firm had a 0.003% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Vivoryon Therapeutics NV, which you can use to evaluate the volatility of the company. Please validate Vivoryon Therapeutics' Coefficient Of Variation of (43,176), risk adjusted performance of 0.0068, and Variance of 27.29 to confirm if the risk estimate we provide is consistent with the expected return of 0.0155%. The entity has a beta of 0.87, which indicates possible diversification benefits within a given portfolio. Vivoryon Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Vivoryon Therapeutics is expected to follow. Vivoryon Therapeutics right now has a risk of 5.26%. Please validate Vivoryon Therapeutics kurtosis, day median price, period momentum indicator, as well as the relationship between the daily balance of power and market facilitation index , to decide if Vivoryon Therapeutics will be following its existing price patterns.
Auto-correlation | -0.13 |
Insignificant reverse predictability
Vivoryon Therapeutics NV has insignificant reverse predictability. Overlapping area represents the amount of predictability between Vivoryon Therapeutics time series from 29th of May 2024 to 27th of August 2024 and 27th of August 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vivoryon Therapeutics price movement. The serial correlation of -0.13 indicates that less than 13.0% of current Vivoryon Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.13 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Vivoryon Therapeutics lagged returns against current returns
Autocorrelation, which is Vivoryon Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vivoryon Therapeutics' stock expected returns. We can calculate the autocorrelation of Vivoryon Therapeutics returns to help us make a trade decision. For example, suppose you find that Vivoryon Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vivoryon Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vivoryon Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vivoryon Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vivoryon Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Vivoryon Therapeutics Lagged Returns
When evaluating Vivoryon Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vivoryon Therapeutics stock have on its future price. Vivoryon Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vivoryon Therapeutics autocorrelation shows the relationship between Vivoryon Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Vivoryon Therapeutics NV.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vivoryon Stock Analysis
When running Vivoryon Therapeutics' price analysis, check to measure Vivoryon Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivoryon Therapeutics is operating at the current time. Most of Vivoryon Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivoryon Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivoryon Therapeutics' price. Additionally, you may evaluate how the addition of Vivoryon Therapeutics to your portfolios can decrease your overall portfolio volatility.